Yaser Ramadan is a Psychiatry physician affiliated with The Ohio State University Wexner Medical Center. OpenAlex indexes 12 publications with 1,185 citations (h-index 10).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1581 Dodd Dr
Columbus, OH 432101257
Telephone
614-292-9780Registry record last updated 8 Jul 2007.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Supernus Pharmaceuticals, Inc.Program year20221 payment
- Supernus Pharmaceuticals, Inc.Program year20211 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
88%Atypical Antipsychotic26.9%Olanzapine23%Quetiapine Fumarate17%Clozapine16%Paliperidone Er10%Invega Sustenna10%Risperidone Odt8%Lurasidone Hcl8%Latuda8%Part D<11 patientsSSRI12.7%Fluoxetine Hcl48%Citalopram Hbr32%Trazodone Hcl20%Part D<11 patients+ 12 more classes in this area
Cardiovascular
9.2%Central alpha-2 Adrenergic Agonist9.2%Clonidine Hcl55%Guanfacine Hcl Er45%Part D<11 patientsMetabolism & gastrointestinal
2.7%Biguanide (metformin)2.7%Metformin Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Placebo-Controlled Pilot Trial of Mecamylamine for Treatment of Autism Spectrum Disorders
Journal of Child and Adolescent Psychopharmacology
2012 - Zinc for Attention-Deficit/Hyperactivity Disorder: Placebo-Controlled Double-Blind Pilot Trial Alone and Combined with Amphetamine
Journal of Child and Adolescent Psychopharmacology
2011 - Medication and Parent Training in Children With Pervasive Developmental Disorders and Serious Behavior Problems: Results From a Randomized Clinical Trial
Journal of the American Academy of Child & Adolescent Psychiatry
2009 - Acetyl-L-Carnitine (ALC) in Attention-Deficit/Hyperactivity Disorder: A Multi-Site, Placebo-Controlled Pilot Trial
Journal of Child and Adolescent Psychopharmacology
2007
Similar KOLs
Other experts from the same institution or the same specialty.
Timothy Pawlik, MD
The Ohio State University Wexner Medical Center
Colleen Cebulla, MD
The Ohio State University Wexner Medical Center
Michael Grever, MD
The Ohio State University Wexner Medical Center
Brad Rovin, MD
The Ohio State University Wexner Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”